| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.22B | 21.71B | 20.60B | 19.31B | 15.40B | 14.65B |
| Gross Profit | 7.49B | 5.02B | 9.62B | 8.58B | 6.39B | 5.89B |
| EBITDA | 15.21B | 14.74B | 9.21B | 8.22B | 6.12B | 5.63B |
| Net Income | 7.09B | 6.89B | 1.73B | 849.00M | 1.68B | 1.56B |
Balance Sheet | ||||||
| Total Assets | 89.96B | 90.01B | 71.41B | 69.28B | 55.66B | 41.96B |
| Cash, Cash Equivalents and Short-Term Investments | 1.39B | 1.34B | 898.00M | 800.00M | 13.30B | 715.00M |
| Total Debt | 44.80B | 46.60B | 47.63B | 45.20B | 36.75B | 22.84B |
| Total Liabilities | 65.64B | 65.73B | 61.01B | 58.84B | 45.56B | 31.43B |
| Stockholders Equity | 17.98B | 24.29B | 10.40B | 10.44B | 10.09B | 10.53B |
Cash Flow | ||||||
| Free Cash Flow | 2.58B | 2.35B | 1.59B | 1.29B | 1.42B | 1.37B |
| Operating Cash Flow | 5.84B | 6.06B | 5.63B | 5.22B | 4.49B | 4.16B |
| Investing Cash Flow | -6.88B | -8.21B | -4.46B | -20.20B | -3.26B | -6.13B |
| Financing Cash Flow | 1.28B | 2.60B | -1.08B | 2.48B | 11.36B | 203.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$12.85B | 13.87 | 35.31% | 2.69% | 0.65% | 15.80% | |
71 Outperform | C$26.78B | 16.49 | 40.28% | 3.94% | 7.44% | 297.46% | |
71 Outperform | C$12.85B | 13.87 | 35.31% | 2.70% | 0.65% | 15.80% | |
64 Neutral | C$30.10B | 4.71 | 31.99% | 7.42% | 0.24% | 3689.26% | |
62 Neutral | C$2.66B | 9.50 | 9.93% | 5.69% | -4.35% | -3.51% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | C$26.55B | 24.88 | 7.68% | 9.49% | 1.03% | 9.34% |